Bio-Rad Laboratories Inc (BIO) Faces Headwinds in Q4, Yet Shows Resilience in Diagnostics Segment [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Net Income : Q4 net income dropped to $349.7 million from $827.7 million in the prior year; full-year net loss reported at $637.3 million. Earnings Per Share : Q4 diluted EPS at $12.14, down from $27.78; full-year loss per share at $21.82. Gross Margin : Q4 gross margin slightly decreased to 53.8%; full-year gross margin at 53.4%. Operational Highlights : Clinical Diagnostics segment grew, while Life Science faced declines; non-GAAP measures provided. 2024 Outlook : Non-GAAP, currency-neutral revenue growth expected between 1.0 to 2.5% with an operating margin of approximately 13.5 to 14.0%. Warning! GuruFocus has detected 3 Warning Sign with BIO. Bio-Rad Laboratories Inc ( NYSE:BIO ) released its 8-K filing on February 15, 2024, disclosing its financial results for the fourth quarter and full year ended December 31, 2023. The company, a global provider of life science research and clinical diagnostics products, faced a challenging year with a notable decrease in net sale
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- Bio-Rad Announces Life Science Group Management Changes [Yahoo! Finance]Yahoo! Finance
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance